Intercos Aktie - ICOS

Intercos Spa (ICOS) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

12,12

( 0,83% )

Gebot

12,00

Fragen

12,30

Volumen

62.408

12,02 Tagesbereich 12,24

10,42 52-Wochen-Bereich 14,26

Marktkapitalisierung

1,168B

Handelsende

12,02

Handelsbeginn

12,02

Letzte Trade

12.12

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

98.550 €

Ausgegebene Aktien

96.364.020

Dividendenrendite (LTM)

0,2 (1,65%)

Kurs-Gewinn-Verhältnis

24,2

Gewinn pro Aktie (EPS)

0,51

Erlöse (LTM)

1,05B

Nettogewinn (LTM)

49,83M

Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers powders, foundation, lipsticks, mascara, nail polish, delivery systems, creams, serums, derm... Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers powders, foundation, lipsticks, mascara, nail polish, delivery systems, creams, serums, dermo cosmetic lotions, and hair care products. The company sells its products to multinational brands, emerging brands, and retailers. Intercos S.p.A. was founded in 1972 and is headquartered in Agrate Brianza, Italy. Mehr anzeigen

Sektor

Consumer Staples

Branche

Consumer Products - Household & Personal

Website

www.intercos.com

Hauptsitz

Agrate Brianza, Italy

Gegründet

1972

Intercos Spa is listed in the Consumer Staples sector of the Italienische Börse with ticker ICOS. The last closing price for Intercos was 12,02 €. Over the last year, Intercos shares have traded in a share price range of 10,42 € to 14,26 €.

Intercos currently has 96.364.020 shares in issue. The market capitalisation of Intercos is 1,17 € billion. Intercos has a price to earnings ratio (PE ratio) of 24.20.

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

- Worldwide Sales of Cialis Top $233 Million - - Net Income Grows to $75.8 Million for 2006 Second Quarter - BOTHELL, Wash., and INDIANAPOLIS...

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

New Survey Reveals State of Emotional and Physical Intimacy of Boomer Relationships BOTHELL, Wash. and INDIANAPOLIS, June 22...

Lilly ICOS LLC Reports Results for First Quarter of 2006

- Cialis Attains Leading ED Market Share Position in Eleven Countries - BOTHELL, Wash. and INDIANAPOLIS, Ind., April 20 /PRNewswire-FirstCall/...

Lilly ICOS LLC Reports First Full-Year Profit in its History

- 2005 Fourth Quarter Net Income Surges to $61.4 Million - - 2005 Worldwide Sales Grow 35% - - Company Provides Update on Clinical Plan for BPH...

Lilly ICOS LLC Reports First Quarterly Profit in its History

BOTHELL, Wash. and INDIANAPOLIS, Ind., Oct. 20 /PRNewswire-FirstCall/ -- Lilly ICOS LLC (Lilly ICOS) (NYSE:LLYNYSE:andNYSE:Nasdaq:NYSE:ICOS) is...

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

-- National Survey Shows Misconceptions Still Prevalent: Nearly One in Three Believe Tight Underwear Can Lead to Erectile Dysfunction NEW YORK...

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since...

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level -- Luke Donald Artwork, Original Vignettes...

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions SAN...

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France - Cialis Achieves 49% of Total Tablet...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.08	-0.655737704918	12.2	12.56	11.62	68888	12.12422652	DE
4	0.12	1	12	12.66	11.54	78893	12.04495045	DE
12	0.54	4.66321243523	11.58	12.8	11.2	90553	12.12140123	DE
26	0.5	4.30292598967	11.62	13.2	10.58	103526	11.92108388	DE
52	-1.44	-10.6194690265	13.56	14.26	10.42	96975	11.98584672	DE
156	-3.48	-22.3076923077	15.6	16.92	10.42	81009	13.43669144	DE
260	-1.88	-13.4285714286	14	17.1	9.755	74789	13.5433582	DE

ICOS - Frequently Asked Questions (FAQ)

What is the current Intercos Spa share price?

The current share price of Intercos Spa is 12,12 €

How many Intercos Spa shares are in issue?

Intercos Spa has 96.364.020 shares in issue

What is the market cap of Intercos Spa?

The market capitalisation of Intercos Spa is EUR 1,17B

What is the 1 year trading range for Intercos Spa share price?

Intercos Spa has traded in the range of 10,42 € to 14,26 € during the past year

What is the PE ratio of Intercos Spa?

The price to earnings ratio of Intercos Spa is 24,2

What is the cash to sales ratio of Intercos Spa?

The cash to sales ratio of Intercos Spa is 1,14

What is the registered address of Intercos Spa?

The registered address for Intercos Spa is Via Guglielmo Marconi 84, Agrate Brianza, Milan, 20864

What is the Intercos Spa website address?

The website address for Intercos Spa is www.intercos.com

Which industry sector does Intercos Spa operate in?

Intercos Spa operates in the Consumer Products - Household & Personal sector

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Intercos Spa (ICOS)

Intercos Spa (ICOS) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Intercos Spa

ICOS Neueste Nachrichten

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

Lilly ICOS LLC Reports Results for First Quarter of 2006

Lilly ICOS LLC Reports First Full-Year Profit in its History

Lilly ICOS LLC Reports First Quarterly Profit in its History

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

ICOS - Frequently Asked Questions (FAQ)

ICOS Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Intercos Spa (ICOS)

Intercos Spa (ICOS) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Intercos Spa

ICOS Neueste Nachrichten

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

Lilly ICOS LLC Reports Results for First Quarter of 2006

Lilly ICOS LLC Reports First Full-Year Profit in its History

Lilly ICOS LLC Reports First Quarterly Profit in its History

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

ICOS - Frequently Asked Questions (FAQ)

ICOS Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen